Emergence of IMP-4-Producing Enterobacter aerogenes Clinical Isolate

Clin Lab. 2018 Jul 1;64(7):1323-1326. doi: 10.7754/Clin.Lab.2018.180211.

Abstract

Background: IMP-4 class B metallo-β-lactamase-producing Enterobacteriaceae are resistant to carbapenems. The aim of this study was to characterize of IMP-4 metallo-β-lactamase (MBL)-producing Enterobacter aerogenes clinical isolate.

Methods: IMP-4 MBL-producing E. aerogenes clinical isolate was collected from a Korean Hospital in 2017. Antimicrobial susceptibility was determined by disk diffusion methods. Further, minimum inhibitory concentrations of β-lactams were determined by Etest. Detection of bla genes was performed by PCR. The genetic organization of class 1 integron carrying the MBL gene cassette was investigated by PCR mapping and sequencing.

Results: E. aerogenes strain YN170501 exhibited resistance to penicillins, cephalosporins, and carbapenems and was susceptible to monobactam, aminoglycosides, fluoroquinolone, tigecycline, and trimethoprim-sulfamethoxazole. The blaIMP-4 gene was located in class 1 integron.

Conclusions: The blaIMP-4 gene has never been reported in Enterobacter aerogenes clinical isolate from Korea.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Carbapenems / pharmacology*
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Enterobacter aerogenes / enzymology*
  • Enterobacter aerogenes / genetics
  • Enterobacter aerogenes / physiology
  • Enterobacteriaceae Infections / microbiology
  • Female
  • Hospitals
  • Humans
  • Integrons / genetics
  • Male
  • Microbial Sensitivity Tests
  • Republic of Korea
  • Sequence Analysis, DNA
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • beta-lactamase IMP-4
  • beta-Lactamases